Exercise: friend or foe?

被引:37
|
作者
Dangardt, Frida J. [1 ]
McKenna, William J. [2 ]
Luescher, Thomas F. [3 ]
Deanfield, John E. [1 ]
机构
[1] Natl Ctr Cardiovasc Prevent & Outcomes, London W1T 7HA, England
[2] UCL, Heart Hosp, London W1G 8PH, England
[3] Univ Zurich Hosp, CH-8091 Zurich, Switzerland
关键词
CHRONIC HEART-FAILURE; ALL-CAUSE MORTALITY; SUDDEN CARDIAC DEATH; RIGHT-VENTRICULAR CARDIOMYOPATHY; PHYSICAL-ACTIVITY QUESTIONNAIRE; CARDIOVASCULAR RISK-FACTORS; ENDURANCE SPORT PRACTICE; EUROPEAN ASSOCIATION; ATRIAL-FIBRILLATION; HYPERTROPHIC CARDIOMYOPATHY;
D O I
10.1038/nrcardio.2013.90
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Physical activity and exercise have been associated with reduced cardiovascular risk, morbidity, and mortality, as well as all-cause mortality, both in the general population and in patients with various forms of cardiovascular disease. Increasing amounts of exercise are associated with incremental reductions in mortality, but considerable benefits have been found even with a low level of exercise. Exercise is beneficial for most individuals, but risks exist. Exercise is associated with reduced long-term morbidity and mortality, but acute exercise can transiently increase the risk of fatal or nonfatal cardiovascular events. Although tragic, these events are very rare, and even to some extent preventable with screening programmes. Low-intensity physical activity is important and beneficial to all individuals, including those with a high risk of adverse cardiovascular events. In individuals who are physically fit and who do not have genetic predisposition to, or signs of, cardiovascular disease, the greater the intensity and amount of exercise, the greater the health benefits. Nevertheless, effective strategies to encourage exercise in the population are lacking. A sustained increase in physical activity is likely to require more than individual advice, and needs to include urban planning and possibly even legislation.
引用
收藏
页码:495 / 507
页数:13
相关论文
共 50 条
  • [1] Exercise: friend or foe?
    Frida J. Dangardt
    William J. McKenna
    Thomas F. Lüscher
    John E. Deanfield
    Nature Reviews Cardiology, 2013, 10 : 495 - 507
  • [2] Exercise: friend and foe
    Marini, M.
    Veicsteinas, A.
    FREE RADICAL RESEARCH, 2009, 43 : 91 - 91
  • [3] Exercise: Friend or Foe?
    Mulder, Kathy
    HAEMOPHILIA, 2014, 20 : 153 - 153
  • [4] Endurance Exercise and the Heart: Friend or Foe?
    Fabian Sanchis-Gomar
    Laura M. Pérez
    Michael J. Joyner
    Herbert Löllgen
    Alejandro Lucia
    Sports Medicine, 2016, 46 : 459 - 466
  • [5] Endurance Exercise and the Heart: Friend or Foe?
    Sanchis-Gomar, Fabian
    Perez, Laura M.
    Joyner, Michael J.
    Loellgen, Herbert
    Lucia, Alejandro
    SPORTS MEDICINE, 2016, 46 (04) : 459 - 466
  • [6] Exercise during chemotherapy: Friend or foe?
    Potiaumpai, Melanie
    Schleicher, Erica A.
    Wang, Ming
    Campbell, Kristin L.
    Sturgeon, Kathleen
    Schmitz, Kathryn H.
    CANCER MEDICINE, 2023, 12 (09): : 10715 - 10724
  • [7] Resveratrol as a supplement to exercise training: friend or foe?
    Buford, Thomas W.
    Anton, Stephen D.
    JOURNAL OF PHYSIOLOGY-LONDON, 2014, 592 (03): : 551 - 552
  • [8] Exercise in the Fight Against Thrombosis: Friend or Foe?
    Adams, Murray
    Williams, Andrew
    Fell, James
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2009, 35 (03): : 261 - 268
  • [9] Exercise in cold: Friend than foe to cardiovascular health
    Feng, Zihang
    Bai, Haomiao
    Sun, Yubo
    Gao, Weilu
    Li, Jia
    Qin, Xiangyang
    Zhang, Xing
    LIFE SCIENCES, 2023, 328
  • [10] Resveratrol as a supplement to exercise training: friend or foe? Reply
    Gliemann, Lasse
    Olesen, Jesper
    Bienso, Rasmus Sjorup
    Mortensen, Stefan Peter
    Nyberg, Michael
    Schmidt, Jakob F.
    Bangsbo, Jens
    Pilegaard, Henriette
    Hellsten, Ylva
    JOURNAL OF PHYSIOLOGY-LONDON, 2014, 592 (03): : 553 - 553